Ophthalmol Glaucoma
Ophthalmol Glaucoma2023Randomized Controlled Trial

Glaucoma Knowledge and Disease Severity in a Veteran Population: The Medication Adherence in Glaucoma to Improve Care (MAGIC) Study.

Visual FieldQuality of Life

Summary

There was no difference in level of glaucoma knowledge based on disease severity.

Abstract

PURPOSE

To assess the relationship between glaucoma knowledge and disease severity.

DESIGN

Substudy of a randomized controlled trial at a single Veterans Affairs (VA) eye clinic.

PARTICIPANTS

Veterans with medically treated open-angle glaucoma who self-reported poor medication adherence.

METHODS

Participants completed a glaucoma knowledge assessment using the 10-question National Eye Health Education Program (NEHEP) Eye-Q Test on glaucoma knowledge. Disease severity was determined using visual field criteria. Multiple linear regression was used to assess the association of NEHEP Eye-Q score and disease severity, adjusting for age, number of glaucoma medications, race, sex, and VA Care Assessment Needs (CAN) score.

MAIN OUTCOME MEASURES

In this cross-sectional, preintervention analysis, the main outcome was glaucoma knowledge as measured by the NEHEP Eye-Q Test.

RESULTS

Among the 200 study participants, glaucoma severity was mild in 53 (27%), moderate in 56 (28%), severe in 74 (37%), and indeterminant in 17 (9%). The NEHEP Eye-Q scores were low across all severity levels. Scored out of 10, the mean (standard deviation) NEHEP Eye-Q scores were 6.06 (1.57) for mild, 6.21 (1.47) for moderate, 6.28 (1.82) for severe, and 5.88 (1.93) for indeterminate stage. There was no evidence of a significant association between NEHEP scores and disease severity categories (P = 0.78). A regression model did not identify a significant estimated association between NEHEP Eye-Q scores and disease severity after adjusting for age, CAN risk score, number of glaucoma medications, race, and sex.

CONCLUSIONS

There was no difference in level of glaucoma knowledge based on disease severity. Education-based interventions may benefit patients across all glaucoma stages. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Keywords

GlaucomaHealth literacyVeterans

In the Knowledge Library

Discussion

Comments and discussion will appear here in a future update.